CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 4 Open-market buy Ex VP, Internal Operations bought 10,000 shares at $4.66 ($46,600)
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $5.02 ($25,075)
- 4 Open-market buy Chief Business Officer bought 30,000 shares at $5.16 ($154,800)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $11.00 ($54,985)
- 4 Open-market buy Director bought 5,000 shares at $10.82 ($54,100)
- 4 Open-market sale Chief Business Officer sold 4,849 shares at $12.01 ($58,236)
- 4 Open-market sale Ex VP, Intern'l Operations sold 3,052 shares at $12.01 ($36,655)
Page 6 of 10 · 184 filings